Sheila Kelly
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Diabetes Management and Research, Atrial Fibrillation Management and Outcomes, Diabetes and associated disorders
Most-Cited Works
- → Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI(2017)43 cited
- → Differences in fall injury hospitalization and related survival rates among older adults across age, sex, and areas of residence in Canada(2015)26 cited
- → Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk(2021)21 cited
- → Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI(2017)14 cited
- → Southern Saskatchewan Ticagrelor Registry experience(2014)12 cited
- → Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective(2013)11 cited
- → Use of vitamin D supplements during infancy in an international feeding trial(2013)10 cited
- → EFFECTS OF TICAGRELOR VERSUS CLOPIDOGREL IN FIBRINOLYTIC-TREATED STEMI PATIENTS UNDERGOING EARLY PCI(2017)1 cited
- → Effects of Baseline Platelet Reactivity on Thrombolysis in Myocardial Infarction Flow and Ischemic Time in Fibrinolysis-treated ST Elevation Myocardial Infarction Patients(2018)1 cited
- → REAL WORLD EXPERIENCE WITH TICAGRELOR IN CENTRAL CANADA(2014)